Abstract
In patients with Guillain-Barré syndrome (GBS) soluble interleukin-2 receptor (sIL-2R) levels were elevated compared with those of patients with other neurologic diseases (OND), and of healthy controls. Smaller increases in sIL-2R levels occurred in OND patients compared to healthy subjects. Monitoring of GBS patients clearly demonstrated that decreases in sIL-2R levels correlated with clinical recovery. Thus, T-cell activation may be relevant in the pathogenesis of GBS.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1302-1305 |
| Number of pages | 4 |
| Journal | Neurology |
| Volume | 41 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1991 |
All Science Journal Classification (ASJC) codes
- Clinical Neurology